Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Thomas Sudhoff"'
Autor:
Daniel Heudobler, Florian Luke, Joachim Hahn, Matthias Grube, Pavla Schlosser, Stephan Kremers, Thomas Sudhoff, Jorg Westermann, Marie Luise Hutter-Kronke, Richard F. Schlenk, Daniela Weber, Peter Paschka, Florian Zeman, Hartmut Dohner, Wolfgang Herr, Albrecht Reichle, Simone Thomas
Publikováno v:
Haematologica, Vol 109, Iss 4 (2023)
Externí odkaz:
https://doaj.org/article/1bb003d3eb94499faafb19a07880a180
Autor:
Alexander Kiani, Romina Roesch, Clemens M. Wendtner, Frank Kullmann, Thomas Kubin, Thomas Südhoff, Marinela Augustin, Markus Schaich, Clemens Müller‐Naendrup, Gerald Illerhaus, Frank Hartmann, Holger Hebart, Ruth Seggewiss‐Bernhardt, Martin Bentz, Ernst Späth‐Schwalbe, Peter Reimer, Ulrich Kaiser, Markus Kapp, Ullrich Graeven, Jens‐Marcus Chemnitz, Jörg Baesecke, Helmut Lambertz, Ralph Naumann
Publikováno v:
Cancer Medicine, Vol 10, Iss 13, Pp 4424-4436 (2021)
Abstract Background Infection with SARS‐CoV‐2 leads to COVID‐19, the course of which is highly variable and depends on numerous patient‐specific risk factors. Patients with tumor diseases are considered to be more susceptible to severe COVID
Externí odkaz:
https://doaj.org/article/189b72c7a94844858de97e82ef190873
Autor:
Daniel Heudobler, Christian Schulz, Jürgen R. Fischer, Peter Staib, Thomas Wehler, Thomas Südhoff, Thomas Schichtl, Jochen Wilke, Joachim Hahn, Florian Lüke, Martin Vogelhuber, Sebastian Klobuch, Tobias Pukrop, Wolfgang Herr, Swantje Held, Kristine Beckers, Gauthier Bouche, Albrecht Reichle
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Most non-small cell lung cancers occur in elderly and frequently comorbid patients. Therefore, it is necessary to evaluate the efficacy of biomodulatory active therapy regimen, concertedly interfering with tumor-associated homeostatic pat
Externí odkaz:
https://doaj.org/article/120f96cd72e34bd0a075f9e90dccdae2